|
1
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shmulevich I: Large-scale molecular
characterization and analysis of gastric cancer. Chin J Cancer.
33:369–370. 2014.PubMed/NCBI
|
|
3
|
Piazuelo MB and Correa P: Gastric cáncer:
Overview. Colomb Med. 44:192–201. 2013.PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alizadeh S, Azizi SG, Soleimani M, Farshi
Y and Khatib Z Kashani: The role of microRNAs in myeloproliferative
neoplasia. Int J Hematol Oncol Stem Cell Res. 10:172–185.
2016.PubMed/NCBI
|
|
6
|
Zhao Y and Srivastava D: A developmental
view of microRNA function. Trends Biochem Sci. 32:189–197. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hata A and Lieberman J: Dysregulation of
microRNA biogenesis and gene silencing in cancer. Sci Signal.
8:re32015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng H, Zhang F and Lin X, Huang C, Zhang
Y, Li Y, Lin J, Chen W and Lin X: MicroRNA-1225-5p inhibits
proliferation and metastasis of gastric carcinoma through
repressing insulin receptor substrate-1 and activation of β-catenin
signaling. Oncotarget. 7:4647–4663. 2016.PubMed/NCBI
|
|
11
|
Zuo QF, Zhang R, Li BS, Zhao YL, Zhuang Y,
Yu T, Gong L, Li S, Xiao B and Zou QM: MicroRNA-141 inhibits tumor
growth and metastasis in gastric cancer by directly targeting
transcriptional co-activator with PDZ-binding motif, TAZ. Cell
Death Dis. 6:e16232015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rawlings-Goss RA, Campbell MC and Tishkoff
SA: Global population-specific variation in miRNA associated with
cancer risk and clinical biomarkers. BMC Med Genomics. 7:532014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim YW, Kim EY, Jeon D, Liu JL, Kim HS,
Choi JW and Ahn WS: Differential microRNA expression signatures and
cell type-specific association with Taxol resistance in ovarian
cancer cells. Drug Des Devel Ther. 8:293–314. 2014.PubMed/NCBI
|
|
14
|
Yuan DD, Zhu ZX, Zhang X and Liu J:
Targeted therapy for gastric cancer: Current status and future
directions (Review). Oncol Rep. 35:1245–1254. 2016.PubMed/NCBI
|
|
15
|
Nishida T, Egashira Y, Akutagawa H, Fujii
M, Uchiyama K, Shibayama Y and Hirose Y: Predictors of lymph node
metastasis in T1 colorectal carcinoma: An immunophenotypic analysis
of 265 patients. Dis Colon Rectum. 57:905–915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Díaz-López A, Moreno-Bueno G and Cano A:
Role of microRNA in epithelial to mesenchymal transition and
metastasis and clinical perspectives. Cancer Manag Res. 6:205–216.
2014.PubMed/NCBI
|
|
17
|
Santos JI, Teixeira AL, Dias F, Gomes M,
Nogueira A, Assis J and Medeiros R: Restoring TGFβ1 pathway-related
microRNAs: Possible impact in metastatic prostate cancer
development. Tumour Biol. 35:6245–6253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang B, Jing C, Wang J, Guo X, Chen Y, Xu
R, Peng L, Liu J and Li L: Identification of microRNAs associated
with lymphangiogenesis in human gastric cancer. Clin Transl Oncol.
16:374–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu L, Ito T, Nakahara T, Nagae K, Fuyuno
Y, Nakao M, Akahoshi M, Nakagawa R, Tu Y, Uchi H, et al:
Upregulation of S100P, receptor for advanced glycation end products
and ezrin in malignant melanoma. J Dermatol. 40:973–979. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fujimoto D, Hirono Y, Goi T, Katayama K,
Matsukawa S and Yamaguchi A: The activation of proteinase-activated
receptor-1 (PAR1) promotes gastric cancer cell alteration of
cellular morphology related to cell motility and invasion. Int J
Oncol. 42:565–573. 2013.PubMed/NCBI
|
|
21
|
Lambert S and Bennett V: Postmitotic
expression of ankyrinR and beta R-spectrin in discrete neuronal
populations of the rat brain. J Neurosci. 13:3725–3735.
1993.PubMed/NCBI
|
|
22
|
De Matteis MA and Morrow JS: The role of
ankyrin and spectrin in membrane transport and domain formation.
Curr Opin Cell Biol. 10:542–549. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu D and Bourguignon LY: Interaction
between CD44 and the repeat domain of ankyrin promotes hyaluronic
acid-mediated ovarian tumor cell migration. J Cell Physiol.
183:182–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bourguignon LY, Zhu H, Shao L and Chen YW:
Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic
breast tumor cell invasion and migration. J Cell Biol. 150:177–191.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu D and Bourguignon LY: The
ankyrin-binding domain of CD44s is involved in regulating
hyaluronic acid-mediated functions and prostate tumor cell
transformation. Cell Motil Cytoskeleton. 39:209–222. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Löhr M and Jesnowski R: Inhibition
of ankyrin-B expression reduces growth and invasion of human
pancreatic ductal adenocarcinoma. Pancreatology. 10:586–596. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sein TT, Thant AA, Hiraiwa Y, Amin AR,
Sohara Y, Liu Y, Matsuda S, Yamamoto T and Hamaguchi M: A role for
FAK in the Concanavalin A-dependent secretion of matrix
metalloproteinase-2 and −9. Oncogene. 19:5539–5542. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY,
Yan M, Gu QL, Zhu ZG and Liu BY: TET1 inhibits gastric cancer
growth and metastasis by PTEN demethylation and re-expression.
Oncotarget. 7:31322–31335. 2016.PubMed/NCBI
|
|
29
|
You T, Gao W, Wei J, Jin X, Zhao Z, Wang C
and Li Y: Overexpression of LIMK1 promotes tumor growth and
metastasis in gastric cancer. Biomed Pharmacother. 69:96–101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu L, Tanimoto A, Murata Y, Sasaguri T,
Fan J, Sasaguri Y and Watanabe T: Matrix metalloproteinase-12 gene
expression in human vascular smooth muscle cells. Genes Cells.
8:225–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie S, Issa R, Sukkar MB, Oltmanns U,
Bhavsar PK, Papi A, Caramori G, Adcock I and Chung KF: Induction
and regulation of matrix metalloproteinase-12 in human airway
smooth muscle cells. Respir Res. 6:1482005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang B, Xu YF, He BS, Pan YQ, Zhang LR,
Zhu C, Qu LL and Wang SK: RNAi-mediated silencing of CD147 inhibits
tumor cell proliferation, invasion and increases chemosensitivity
to cisplatin in SGC7901 cells in vitro. J Exp Clin Cancer Res.
29:612010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lv FZ, Wang JL, Wu Y, Chen HF and Shen XY:
Knockdown of MMP12 inhibits the growth and invasion of lung
adenocarcinoma cells. Int J Immunopathol Pharmacol. 28:77–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Turley EA, Noble PW and Bourguignon LY:
Signaling properties of hyaluronan receptors. J Biol Chem.
277:4589–4592. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bourguignon LY, Singleton PA, Diedrich F,
Stern R and Gilad E: CD44 interaction with Na+-H+ exchanger (NHE1)
creates acidic microenvironments leading to hyaluronidase-2 and
cathepsin B activation and breast tumor cell invasion. J Biol Chem.
279:26991–27007. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bourguignon LY, Zhu H, Zhou B, Diedrich F,
Singleton PA and Hung MC: Hyaluronan promotes CD44v3-Vav2
interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling
during ovarian tumor cell migration and growth. J Biol Chem.
276:48679–48692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lokeshwar VB, Fregien N and Bourguignon
LY: Ankyrin-binding domain of CD44(GP85) is required for the
expression of hyaluronic acid-mediated adhesion function. J Cell
Biol. 126:1099–1109. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang W, Zhang Y, Kane KT, Collins MA,
Simeone DM, diMagliano MP and Nguyen KT: CD44 regulates pancreatic
cancer invasion through MT1-MMP. Mol Cancer Res. 13:9–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao J, Yang C, Guo S and Wu Y: GM130
regulates epithelial-to-mesenchymal transition and invasion of
gastric cancer cells via snail. Int J Clin Exp Pathol.
8:10784–10791. 2015.PubMed/NCBI
|
|
40
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
